nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—hypertension—adrenal gland cancer	0.663	1	CtDrD
Bepridil—ABCB1—adrenal gland cancer	0.196	1	CbGaD
Bepridil—CALM2—adrenal medulla—adrenal gland cancer	0.00533	0.105	CbGeAlD
Bepridil—CALM1—adrenal medulla—adrenal gland cancer	0.0053	0.104	CbGeAlD
Bepridil—CALM1—sympathetic nervous system—adrenal gland cancer	0.00353	0.0692	CbGeAlD
Bepridil—TNNC1—adrenal cortex—adrenal gland cancer	0.0015	0.0295	CbGeAlD
Bepridil—PDE1B—gonad—adrenal gland cancer	0.0013	0.0255	CbGeAlD
Bepridil—CACNA1A—adrenal gland—adrenal gland cancer	0.0013	0.0255	CbGeAlD
Bepridil—TNNC1—cardiac atrium—adrenal gland cancer	0.00124	0.0244	CbGeAlD
Bepridil—KCNQ1—adrenal cortex—adrenal gland cancer	0.00122	0.024	CbGeAlD
Bepridil—TNNC1—pituitary gland—adrenal gland cancer	0.00122	0.0238	CbGeAlD
Bepridil—PDE1B—adrenal gland—adrenal gland cancer	0.00113	0.0222	CbGeAlD
Bepridil—PDE1A—gonad—adrenal gland cancer	0.00109	0.0214	CbGeAlD
Bepridil—TNNC1—adrenal gland—adrenal gland cancer	0.00109	0.0213	CbGeAlD
Bepridil—CYP2D6—urine—adrenal gland cancer	0.00107	0.021	CbGeAlD
Bepridil—CACNA2D2—cardiac atrium—adrenal gland cancer	0.00105	0.0205	CbGeAlD
Bepridil—CACNA2D2—pituitary gland—adrenal gland cancer	0.00102	0.0201	CbGeAlD
Bepridil—KCNQ1—cardiac atrium—adrenal gland cancer	0.00101	0.0198	CbGeAlD
Bepridil—KCNQ1—pituitary gland—adrenal gland cancer	0.000987	0.0194	CbGeAlD
Bepridil—PDE1A—adrenal gland—adrenal gland cancer	0.000949	0.0186	CbGeAlD
Bepridil—CACNA2D2—adrenal gland—adrenal gland cancer	0.000913	0.0179	CbGeAlD
Bepridil—KCNQ1—adrenal gland—adrenal gland cancer	0.000882	0.0173	CbGeAlD
Bepridil—CACNA1H—gonad—adrenal gland cancer	0.00085	0.0167	CbGeAlD
Bepridil—CACNA1D—adrenal cortex—adrenal gland cancer	0.000847	0.0166	CbGeAlD
Bepridil—CACNA1H—pituitary gland—adrenal gland cancer	0.000829	0.0163	CbGeAlD
Bepridil—CACNA1H—adrenal gland—adrenal gland cancer	0.000741	0.0145	CbGeAlD
Bepridil—CACNA1D—cardiac atrium—adrenal gland cancer	0.000701	0.0138	CbGeAlD
Bepridil—CACNA1D—pituitary gland—adrenal gland cancer	0.000684	0.0134	CbGeAlD
Bepridil—CALM3—adrenal cortex—adrenal gland cancer	0.000655	0.0129	CbGeAlD
Bepridil—CACNA1C—cardiac atrium—adrenal gland cancer	0.000647	0.0127	CbGeAlD
Bepridil—CACNA1C—pituitary gland—adrenal gland cancer	0.000632	0.0124	CbGeAlD
Bepridil—CACNA1D—adrenal gland—adrenal gland cancer	0.000611	0.012	CbGeAlD
Bepridil—ATP1A1—adrenal cortex—adrenal gland cancer	0.000584	0.0115	CbGeAlD
Bepridil—CACNA1C—adrenal gland—adrenal gland cancer	0.000564	0.0111	CbGeAlD
Bepridil—CALM3—cardiac atrium—adrenal gland cancer	0.000542	0.0106	CbGeAlD
Bepridil—CALM3—pituitary gland—adrenal gland cancer	0.000529	0.0104	CbGeAlD
Bepridil—CALM2—adrenal cortex—adrenal gland cancer	0.000514	0.0101	CbGeAlD
Bepridil—CALM1—adrenal cortex—adrenal gland cancer	0.000512	0.01	CbGeAlD
Bepridil—ATP1A1—gonad—adrenal gland cancer	0.000484	0.00949	CbGeAlD
Bepridil—ATP1A1—cardiac atrium—adrenal gland cancer	0.000483	0.00948	CbGeAlD
Bepridil—CALM3—adrenal gland—adrenal gland cancer	0.000473	0.00928	CbGeAlD
Bepridil—ATP1A1—pituitary gland—adrenal gland cancer	0.000472	0.00926	CbGeAlD
Bepridil—CALM2—gonad—adrenal gland cancer	0.000426	0.00836	CbGeAlD
Bepridil—CALM2—cardiac atrium—adrenal gland cancer	0.000425	0.00835	CbGeAlD
Bepridil—CALM1—gonad—adrenal gland cancer	0.000424	0.00832	CbGeAlD
Bepridil—CALM1—cardiac atrium—adrenal gland cancer	0.000423	0.00831	CbGeAlD
Bepridil—ATP1A1—adrenal gland—adrenal gland cancer	0.000422	0.00827	CbGeAlD
Bepridil—CALM2—pituitary gland—adrenal gland cancer	0.000416	0.00816	CbGeAlD
Bepridil—CALM1—pituitary gland—adrenal gland cancer	0.000414	0.00812	CbGeAlD
Bepridil—KCNH2—cardiac atrium—adrenal gland cancer	0.000385	0.00756	CbGeAlD
Bepridil—KCNH2—pituitary gland—adrenal gland cancer	0.000376	0.00739	CbGeAlD
Bepridil—CALM2—adrenal gland—adrenal gland cancer	0.000371	0.00729	CbGeAlD
Bepridil—CALM1—adrenal gland—adrenal gland cancer	0.00037	0.00725	CbGeAlD
Bepridil—KCNH2—adrenal gland—adrenal gland cancer	0.000336	0.0066	CbGeAlD
Bepridil—ABCB1—adrenal cortex—adrenal gland cancer	0.000204	0.00401	CbGeAlD
Bepridil—ABCB1—gonad—adrenal gland cancer	0.000169	0.00332	CbGeAlD
Bepridil—ABCB1—pituitary gland—adrenal gland cancer	0.000165	0.00324	CbGeAlD
Bepridil—ABCB1—adrenal gland—adrenal gland cancer	0.000148	0.0029	CbGeAlD
Bepridil—CALM3—Adaptive Immune System—CDC42—adrenal gland cancer	1.81e-05	0.000201	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—ABCB1—adrenal gland cancer	1.8e-05	0.000201	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CDC42—adrenal gland cancer	1.79e-05	0.000199	CbGpPWpGaD
Bepridil—PDE1B—Disease—BAD—adrenal gland cancer	1.78e-05	0.000198	CbGpPWpGaD
Bepridil—CALM1—Metabolism—RRM1—adrenal gland cancer	1.78e-05	0.000198	CbGpPWpGaD
Bepridil—CALM1—Metabolism—SDHD—adrenal gland cancer	1.78e-05	0.000198	CbGpPWpGaD
Bepridil—CALM2—Metabolism—RRM1—adrenal gland cancer	1.78e-05	0.000198	CbGpPWpGaD
Bepridil—CALM2—Metabolism—SDHD—adrenal gland cancer	1.78e-05	0.000198	CbGpPWpGaD
Bepridil—PDE1A—Disease—BRAF—adrenal gland cancer	1.77e-05	0.000197	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.77e-05	0.000197	CbGpPWpGaD
Bepridil—CALM2—RNF mutants show enhanced WNT signaling and proliferation—CTNNB1—adrenal gland cancer	1.76e-05	0.000196	CbGpPWpGaD
Bepridil—CALM1—RNF mutants show enhanced WNT signaling and proliferation—CTNNB1—adrenal gland cancer	1.76e-05	0.000196	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—EGFR—adrenal gland cancer	1.76e-05	0.000196	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	1.76e-05	0.000196	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—EGFR—adrenal gland cancer	1.76e-05	0.000196	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—TP53—adrenal gland cancer	1.76e-05	0.000196	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—EGFR—adrenal gland cancer	1.76e-05	0.000196	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CDC42—adrenal gland cancer	1.75e-05	0.000194	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CDC42—adrenal gland cancer	1.75e-05	0.000194	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR—EGFR—adrenal gland cancer	1.75e-05	0.000194	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	1.73e-05	0.000192	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—PTGS2—adrenal gland cancer	1.73e-05	0.000192	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—EGFR—adrenal gland cancer	1.73e-05	0.000192	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—EGFR—adrenal gland cancer	1.72e-05	0.000192	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IGF2—adrenal gland cancer	1.72e-05	0.000192	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—GNAS—adrenal gland cancer	1.71e-05	0.00019	CbGpPWpGaD
Bepridil—CALM3—Disease—SPRY2—adrenal gland cancer	1.71e-05	0.00019	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—EGFR—adrenal gland cancer	1.7e-05	0.00019	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—EGFR—adrenal gland cancer	1.7e-05	0.00019	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—EGFR—adrenal gland cancer	1.7e-05	0.00019	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—EGFR—adrenal gland cancer	1.7e-05	0.00019	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	1.7e-05	0.00019	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	1.7e-05	0.00019	CbGpPWpGaD
Bepridil—CALM3—Signaling by WNT in cancer—CTNNB1—adrenal gland cancer	1.69e-05	0.000188	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—EGFR—adrenal gland cancer	1.69e-05	0.000188	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—EGFR—adrenal gland cancer	1.69e-05	0.000188	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	1.67e-05	0.000186	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	1.67e-05	0.000186	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—EGFR—adrenal gland cancer	1.67e-05	0.000185	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—EGFR—adrenal gland cancer	1.67e-05	0.000185	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IGF1R—adrenal gland cancer	1.67e-05	0.000185	CbGpPWpGaD
Bepridil—CALM1—Disease—SPRY2—adrenal gland cancer	1.65e-05	0.000184	CbGpPWpGaD
Bepridil—CALM2—Disease—SPRY2—adrenal gland cancer	1.65e-05	0.000184	CbGpPWpGaD
Bepridil—CALM2—Signaling by WNT in cancer—CTNNB1—adrenal gland cancer	1.64e-05	0.000182	CbGpPWpGaD
Bepridil—CALM1—Signaling by WNT in cancer—CTNNB1—adrenal gland cancer	1.64e-05	0.000182	CbGpPWpGaD
Bepridil—CALM3—B Cell Activation—EGFR—adrenal gland cancer	1.63e-05	0.000181	CbGpPWpGaD
Bepridil—PDE1B—Disease—BRAF—adrenal gland cancer	1.62e-05	0.00018	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.62e-05	0.00018	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—TP53—adrenal gland cancer	1.61e-05	0.000179	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.59e-05	0.000176	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—EGFR—adrenal gland cancer	1.58e-05	0.000175	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—EGFR—adrenal gland cancer	1.58e-05	0.000175	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TERT—adrenal gland cancer	1.57e-05	0.000174	CbGpPWpGaD
Bepridil—CALM3—Disease—MEN1—adrenal gland cancer	1.56e-05	0.000174	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	1.56e-05	0.000174	CbGpPWpGaD
Bepridil—CALM1—Disease—MEN1—adrenal gland cancer	1.51e-05	0.000168	CbGpPWpGaD
Bepridil—CALM2—Disease—MEN1—adrenal gland cancer	1.51e-05	0.000168	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	1.51e-05	0.000168	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	1.51e-05	0.000168	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TERT—adrenal gland cancer	1.43e-05	0.000159	CbGpPWpGaD
Bepridil—PDE1A—Disease—PTGS2—adrenal gland cancer	1.43e-05	0.000159	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PRKACA—adrenal gland cancer	1.41e-05	0.000157	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—POMC—adrenal gland cancer	1.41e-05	0.000157	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—CTNNB1—adrenal gland cancer	1.39e-05	0.000155	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.39e-05	0.000155	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.39e-05	0.000155	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CTNNB1—adrenal gland cancer	1.39e-05	0.000154	CbGpPWpGaD
Bepridil—CALM3—Metabolism—MED12—adrenal gland cancer	1.37e-05	0.000152	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PRKACA—adrenal gland cancer	1.37e-05	0.000152	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PRKACA—adrenal gland cancer	1.37e-05	0.000152	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—BAD—adrenal gland cancer	1.36e-05	0.000152	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—CTNNB1—adrenal gland cancer	1.35e-05	0.00015	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—CTNNB1—adrenal gland cancer	1.35e-05	0.00015	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MED12—adrenal gland cancer	1.32e-05	0.000147	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MED12—adrenal gland cancer	1.32e-05	0.000147	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—BAD—adrenal gland cancer	1.31e-05	0.000146	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—RRM1—adrenal gland cancer	1.31e-05	0.000146	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SDHD—adrenal gland cancer	1.31e-05	0.000146	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.31e-05	0.000146	CbGpPWpGaD
Bepridil—PDE1B—Disease—PTGS2—adrenal gland cancer	1.31e-05	0.000146	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GNRH1—adrenal gland cancer	1.31e-05	0.000145	CbGpPWpGaD
Bepridil—CALM3—Immune System—PRKACA—adrenal gland cancer	1.29e-05	0.000144	CbGpPWpGaD
Bepridil—PDE1A—Disease—CTNNB1—adrenal gland cancer	1.28e-05	0.000143	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—BAD—adrenal gland cancer	1.27e-05	0.000141	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—BAD—adrenal gland cancer	1.27e-05	0.000141	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CTNNB1—adrenal gland cancer	1.27e-05	0.000141	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GNRH1—adrenal gland cancer	1.26e-05	0.000141	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GNRH1—adrenal gland cancer	1.26e-05	0.000141	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—BAD—adrenal gland cancer	1.26e-05	0.00014	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—POMC—adrenal gland cancer	1.26e-05	0.00014	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.26e-05	0.00014	CbGpPWpGaD
Bepridil—CALM2—Immune System—PRKACA—adrenal gland cancer	1.25e-05	0.000139	CbGpPWpGaD
Bepridil—CALM1—Immune System—PRKACA—adrenal gland cancer	1.25e-05	0.000139	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—BAD—adrenal gland cancer	1.25e-05	0.000139	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—BRAF—adrenal gland cancer	1.24e-05	0.000138	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—POMC—adrenal gland cancer	1.24e-05	0.000138	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—BAD—adrenal gland cancer	1.22e-05	0.000136	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—BAD—adrenal gland cancer	1.22e-05	0.000136	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.2e-05	0.000134	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—EGFR—adrenal gland cancer	1.2e-05	0.000133	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CDC42—adrenal gland cancer	1.2e-05	0.000133	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SPRY2—adrenal gland cancer	1.19e-05	0.000133	CbGpPWpGaD
Bepridil—CALM3—Disease—PRKACA—adrenal gland cancer	1.19e-05	0.000133	CbGpPWpGaD
Bepridil—PDE1B—Disease—CTNNB1—adrenal gland cancer	1.17e-05	0.00013	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TSHR—adrenal gland cancer	1.16e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—EGFR—adrenal gland cancer	1.16e-05	0.000129	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—EGFR—adrenal gland cancer	1.16e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CDC42—adrenal gland cancer	1.16e-05	0.000129	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CDC42—adrenal gland cancer	1.16e-05	0.000129	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SPRY2—adrenal gland cancer	1.16e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SPRY2—adrenal gland cancer	1.16e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Disease—PRKACA—adrenal gland cancer	1.15e-05	0.000128	CbGpPWpGaD
Bepridil—CALM1—Disease—PRKACA—adrenal gland cancer	1.15e-05	0.000128	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—POMC—adrenal gland cancer	1.15e-05	0.000128	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—GNAS—adrenal gland cancer	1.15e-05	0.000127	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—BRAF—adrenal gland cancer	1.14e-05	0.000126	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TSHR—adrenal gland cancer	1.13e-05	0.000125	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TSHR—adrenal gland cancer	1.13e-05	0.000125	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—PTGS2—adrenal gland cancer	1.12e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—GNAS—adrenal gland cancer	1.11e-05	0.000123	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—GNAS—adrenal gland cancer	1.11e-05	0.000123	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—EGFR—adrenal gland cancer	1.1e-05	0.000122	CbGpPWpGaD
Bepridil—PDE1A—Immune System—EGFR—adrenal gland cancer	1.1e-05	0.000122	CbGpPWpGaD
Bepridil—CALM3—Immune System—CDC42—adrenal gland cancer	1.1e-05	0.000122	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MEN1—adrenal gland cancer	1.09e-05	0.000122	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDC42—adrenal gland cancer	1.06e-05	0.000118	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDC42—adrenal gland cancer	1.06e-05	0.000118	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MEN1—adrenal gland cancer	1.06e-05	0.000118	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MEN1—adrenal gland cancer	1.06e-05	0.000118	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.05e-05	0.000117	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MED12—adrenal gland cancer	1.04e-05	0.000115	CbGpPWpGaD
Bepridil—PDE1A—Disease—EGFR—adrenal gland cancer	1.01e-05	0.000113	CbGpPWpGaD
Bepridil—CALM3—Disease—CDC42—adrenal gland cancer	1.01e-05	0.000113	CbGpPWpGaD
Bepridil—PDE1B—Immune System—EGFR—adrenal gland cancer	1.01e-05	0.000112	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PRKACA—adrenal gland cancer	9.99e-06	0.000111	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—PTGS2—adrenal gland cancer	9.87e-06	0.00011	CbGpPWpGaD
Bepridil—CALM2—Disease—CDC42—adrenal gland cancer	9.79e-06	0.000109	CbGpPWpGaD
Bepridil—CALM1—Disease—CDC42—adrenal gland cancer	9.79e-06	0.000109	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MED12—adrenal gland cancer	9.78e-06	0.000109	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PRKACA—adrenal gland cancer	9.66e-06	0.000107	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PRKACA—adrenal gland cancer	9.66e-06	0.000107	CbGpPWpGaD
Bepridil—PDE1B—Disease—EGFR—adrenal gland cancer	9.28e-06	0.000103	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CTNNB1—adrenal gland cancer	8.97e-06	9.98e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—CTNNB1—adrenal gland cancer	8.64e-06	9.61e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CTNNB1—adrenal gland cancer	8.36e-06	9.3e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CTNNB1—adrenal gland cancer	8.36e-06	9.3e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PRKACA—adrenal gland cancer	8.35e-06	9.29e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CTNNB1—adrenal gland cancer	8.21e-06	9.13e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—TERT—adrenal gland cancer	8.12e-06	9.03e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GNAS—adrenal gland cancer	8.1e-06	9.01e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PRKACA—adrenal gland cancer	8.08e-06	8.99e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PRKACA—adrenal gland cancer	8.08e-06	8.99e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ABCB1—adrenal gland cancer	7.94e-06	8.84e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—TERT—adrenal gland cancer	7.85e-06	8.73e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—TERT—adrenal gland cancer	7.85e-06	8.73e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GNAS—adrenal gland cancer	7.83e-06	8.71e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GNAS—adrenal gland cancer	7.83e-06	8.71e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—POMC—adrenal gland cancer	7.72e-06	8.58e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ABCB1—adrenal gland cancer	7.69e-06	8.55e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ABCB1—adrenal gland cancer	7.69e-06	8.55e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—BAD—adrenal gland cancer	7.65e-06	8.51e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PRKACA—adrenal gland cancer	7.57e-06	8.42e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—POMC—adrenal gland cancer	7.46e-06	8.3e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—POMC—adrenal gland cancer	7.46e-06	8.3e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—BAD—adrenal gland cancer	7.4e-06	8.23e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—BAD—adrenal gland cancer	7.4e-06	8.23e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	7.13e-06	7.94e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EGFR—adrenal gland cancer	7.11e-06	7.91e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDC42—adrenal gland cancer	7.09e-06	7.88e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—BAD—adrenal gland cancer	7.06e-06	7.86e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDC42—adrenal gland cancer	6.85e-06	7.62e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDC42—adrenal gland cancer	6.85e-06	7.62e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EGFR—adrenal gland cancer	6.84e-06	7.61e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—BAD—adrenal gland cancer	6.83e-06	7.6e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—BAD—adrenal gland cancer	6.83e-06	7.6e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF2—adrenal gland cancer	6.83e-06	7.6e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GNAS—adrenal gland cancer	6.77e-06	7.53e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EGFR—adrenal gland cancer	6.62e-06	7.37e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EGFR—adrenal gland cancer	6.62e-06	7.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF2—adrenal gland cancer	6.61e-06	7.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF2—adrenal gland cancer	6.61e-06	7.35e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1R—adrenal gland cancer	6.6e-06	7.35e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—EGFR—adrenal gland cancer	6.57e-06	7.31e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GNAS—adrenal gland cancer	6.55e-06	7.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GNAS—adrenal gland cancer	6.55e-06	7.29e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EGFR—adrenal gland cancer	6.5e-06	7.23e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—BRAF—adrenal gland cancer	6.43e-06	7.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1R—adrenal gland cancer	6.39e-06	7.11e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1R—adrenal gland cancer	6.39e-06	7.11e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—adrenal gland cancer	6.38e-06	7.1e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—EGFR—adrenal gland cancer	6.36e-06	7.07e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—EGFR—adrenal gland cancer	6.36e-06	7.07e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—BRAF—adrenal gland cancer	6.22e-06	6.92e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—BRAF—adrenal gland cancer	6.22e-06	6.92e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—adrenal gland cancer	6.17e-06	6.87e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—adrenal gland cancer	6.17e-06	6.87e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GNAS—adrenal gland cancer	6.14e-06	6.83e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—adrenal gland cancer	5.97e-06	6.64e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GNAS—adrenal gland cancer	5.78e-06	6.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TERT—adrenal gland cancer	5.68e-06	6.32e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	5.67e-06	6.31e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TERT—adrenal gland cancer	5.5e-06	6.12e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TERT—adrenal gland cancer	5.5e-06	6.12e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—adrenal gland cancer	5.46e-06	6.07e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—POMC—adrenal gland cancer	5.45e-06	6.06e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—POMC—adrenal gland cancer	5.27e-06	5.87e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—POMC—adrenal gland cancer	5.27e-06	5.87e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—adrenal gland cancer	5.19e-06	5.78e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CTNNB1—adrenal gland cancer	5.03e-06	5.6e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—adrenal gland cancer	5.02e-06	5.59e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—adrenal gland cancer	5.02e-06	5.59e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—BAD—adrenal gland cancer	4.94e-06	5.5e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CTNNB1—adrenal gland cancer	4.87e-06	5.41e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CTNNB1—adrenal gland cancer	4.87e-06	5.41e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—BAD—adrenal gland cancer	4.78e-06	5.32e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—BAD—adrenal gland cancer	4.78e-06	5.32e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CTNNB1—adrenal gland cancer	4.65e-06	5.17e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—POMC—adrenal gland cancer	4.56e-06	5.07e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—BRAF—adrenal gland cancer	4.5e-06	5.01e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CTNNB1—adrenal gland cancer	4.49e-06	5e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CTNNB1—adrenal gland cancer	4.49e-06	5e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—POMC—adrenal gland cancer	4.41e-06	4.91e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—POMC—adrenal gland cancer	4.41e-06	4.91e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—adrenal gland cancer	4.36e-06	4.85e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—BRAF—adrenal gland cancer	4.35e-06	4.84e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—BRAF—adrenal gland cancer	4.35e-06	4.84e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—adrenal gland cancer	4.35e-06	4.84e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—adrenal gland cancer	4.22e-06	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—adrenal gland cancer	4.22e-06	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—adrenal gland cancer	4.21e-06	4.68e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—adrenal gland cancer	4.21e-06	4.68e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—POMC—adrenal gland cancer	4.13e-06	4.6e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—adrenal gland cancer	3.99e-06	4.43e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—POMC—adrenal gland cancer	3.89e-06	4.33e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—adrenal gland cancer	3.86e-06	4.29e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—adrenal gland cancer	3.86e-06	4.29e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—adrenal gland cancer	3.68e-06	4.09e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—adrenal gland cancer	3.56e-06	3.96e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—adrenal gland cancer	3.56e-06	3.96e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—adrenal gland cancer	3.3e-06	3.67e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CTNNB1—adrenal gland cancer	3.25e-06	3.62e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CTNNB1—adrenal gland cancer	3.15e-06	3.5e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.15e-06	3.5e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	3.11e-06	3.45e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—adrenal gland cancer	2.58e-06	2.87e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—adrenal gland cancer	2.49e-06	2.77e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—adrenal gland cancer	2.49e-06	2.77e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—adrenal gland cancer	2.16e-06	2.41e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—adrenal gland cancer	2.09e-06	2.33e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—adrenal gland cancer	2.09e-06	2.33e-05	CbGpPWpGaD
